Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan + amlodipine versus amlodipine monotherapy in essential hypertension non-responders
2007-002421-68Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of telmisartan and amlodipine in essential hypertension (3 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Change from baseline in seated trough diastolic blood pressure. Started Aug 2007; status: completed.
02
Drugs
telmisartanamlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2007-002421-68.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002421-68.